Desmedt S, Desmedt V, Delanghe JR, Speeckaert R, Speeckaert MM. The intriguing role of soluble urokinase receptor in inflammatory diseases. Crit Rev Clin Lab Sci. 2017;54:117–33.

Article  CAS  PubMed  Google Scholar 

Huai Q, Mazar AP, Kuo A, Parry GC, Shaw DE, Callahan J, et al. Structure of human urokinase plasminogen activator in complex with its receptor. Science (New York, NY). 2006;311:656–9.

Article  CAS  Google Scholar 

Galat A. The three-fingered protein domain of the human genome. Cell Mol Life Sci. 2008;65:3481–93.

Article  CAS  PubMed  Google Scholar 

Haupt TH, Kallemose T, Ladelund S, Rasmussen LJ, Thorball CW, Andersen O, et al. Risk factors associated with serum levels of the inflammatory biomarker soluble urokinase plasminogen activator receptor in a general population. Biomark Insights. 2014;9:91–100.

Article  PubMed  PubMed Central  Google Scholar 

Reisinger AC, Niedrist T, Posch F, Hatzl S, Hackl G, Prattes J, et al. Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit. Sci Rep. 2021;11:17476.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hayek SS, Leaf DE, Samman Tahhan A, Raad M, Sharma S, Waikar SS, et al. Soluble urokinase receptor and acute kidney injury. N Engl J Med. 2020;382:416–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raggam RB, Wagner J, Pruller F, Grisold A, Leitner E, Zollner-Schwetz I, et al. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome. J Intern Med. 2014;276:651–8.

Article  CAS  PubMed  Google Scholar 

Reisinger AC, Hackl G, Niedrist T, Hoenigl M, Eller P, Prattes J. SuPAR levels in BAL fluid from patients with acute respiratory distress syndrome—a pilot study. Crit Care. 2020;24:576.

Article  PubMed  PubMed Central  Google Scholar 

Hatzl S, Reisinger AC, Posch F, Prattes J, Stradner M, Pilz S, et al. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study. Crit Care. 2021;25:335.

Article  PubMed  PubMed Central  Google Scholar 

Schauwvlieghe A, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6:782–92.

Article  PubMed  Google Scholar 

Tortorano AM, Dho G, Prigitano A, Breda G, Grancini A, Emmi V, et al. Invasive fungal infections in the intensive care unit: a multicentre, prospective, observational study in Italy (2006–2008). Mycoses. 2012;55:73–9.

Article  PubMed  Google Scholar 

Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307:2526–33.

Google Scholar 

Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21:e149–62.

Article  CAS  PubMed  Google Scholar 

Blot SI, Taccone FS, Van den Abeele AM, Bulpa P, Meersseman W, Brusselaers N, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012;186:56–64.

Article  PubMed  Google Scholar 

Prattes J, Valentin T, Hoenigl M, Talakic E, Reisinger AC, Eller P. Invasive pulmonary aspergillosis complicating COVID-19 in the ICU—A case report. Med Mycol Case Rep. 2021;31:2–5.

Article  PubMed  Google Scholar 

Prattes J, Wauters J, Giacobbe DR, Salmanton-Garcia J, Maertens J, Bourgeois M, et al. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect. 2022;28:580–7.

Article  CAS  PubMed  Google Scholar